Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908733-08-000158
Filing Date
2008-01-23
Accepted
2008-01-23 14:19:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 NEUROGEN CORP 13G neurogencorp.htm SC 13G 11669
  Complete submission text file 0000908733-08-000158.txt   13883
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Subject) CIK: 0000849043 (see all company filings)

EIN.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41776 | Film No.: 08544217
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000